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ABSTRACT
We recently demonstrated that thyroid hormone is an important
regulator of mitochondrial gene expression during brain develop-
ment. To gain further insights into the consequences of this regula-
tion, we have performed functional and structural analysis of brain
mitochondria from control and hypothyroid neonatal rats. Flow cy-
tometric analysis showed a significant decrease in the mitochondrial
transmembrane potential in hypothyroid animals compared with con-
trols, which was reversed after 48 h, but not after 2 h, of thyroid
hormone administration, suggesting that the functional alterations
observed are the consequence of changes in mitochondrial gene ex-
pression. In addition, band shift studies showed a protein bound to the
rat mitochondrial promoter differentially regulated by thyroid state.
Electron microscopic analysis of cerebral cortex, striatum, and hip-
pocampus revealed marked differences in the morphology of neuronal
mitochondria from control and hypothyroid neonates. Hypothyroid
mitochondria presented a decrease in the area of the inner membrane
plus cristae in all areas studied, except for the hippocampal CA1
neurons and nonneuronal cell types. The observations reported here
provide a basis for the known biochemical action of thyroid hormone
on brain development. (Endocrinology 138: 3771–3778, 1997)
THYROID HORMONE (T3) is an important effector ofdevelopment, cell growth, and metabolism of verte-
brate organisms (1). Most of these effects are mediated by
specific nuclear receptors that belong to a superfamily of
nuclear receptors that includes receptors for steroids, vita-
min D3, retinoic acid, and peroxisome proliferators (2). These
receptors act as transcription factors regulating gene tran-
scription in response to the binding of their respective li-
gands (2). The hormonal regulation of gene expression is
exerted by the receptors upon binding to hormone response
elements, thus activating or repressing the transcription of
specific target genes (3). Vertebrates produce different iso-
forms of thyroid hormone receptors from two related genes,
a and b, which are differentially expressed in a tissue-specific
manner (4, 5).
One of the most important effects of thyroid hormone
concerns neonatal brain development. The association of
congenital hypothyroidism with abnormal development and
mental retardation has been extensively documented (6). In
humans, thyroid hormone deficiency has been associated
with irreversible mental retardation and profound neuro-
logical deficits, including deafness and movement disorders
(7). Also, experimental hypothyroidism in the rat results in
impaired brain development with a diminished interneuro-
nal connectivity, decreased myelination, defective cell mi-
gration, and alterations in levels of neurotransmitters (6).
There is a critical period during which appropriate thyroid
hormone levels are essential for normal brain development.
In humans, this period was considered to begin late in ges-
tation and to extend through 1–2 yr of age. In rats, this critical
period was thought to occur during the first 15 days after
birth. This is an important period for neuronal differentia-
tion, maturation, and development of neuronal processes.
We have observed that during this time, both the number of
T3 receptors and the amount of receptor messenger RNA rise
together with the level of T3 in brain (5, 8). More recently,
however, the idea has arisen that thyroid hormone is re-
quired earlier in development (9, 10). Understanding the
mechanisms behind thyroid hormone effects on brain de-
velopment has been a challenge for many years, and despite
all the descriptions of functional and morphological defects
in the developing brain in hypothyroidism, only recently
have several reports shown specific genes that are targets of
T3 action in this tissue (10–14).
Thyroid hormone has been reported to play an important
role in the regulation of mitochondrial function in several
tissues, such as liver, kidney, and skeletal muscle. T3 stim-
ulates mitochondrial metabolism, and T3 deficiency results in
decreased respiratory activities (15, 16). In general, thyroid
hormone causes an increase in the overall capacity of mito-
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chondrial electron transport chain proteins. This regulation
of mitochondrial function takes place in the adult animal as
well as during development (16–20). In accordance with its
role in growth and development, thyroid hormone also plays
an important role in hepatic mitochondrial maturation (18,
19). At least in part, thyroid hormone can affect mitochon-
drial respiratory function by controlling the expression of
nuclear-encoded respiratory genes as well as mitochondri-
ally encoded transcripts (20–22). However, each tissue re-
sponds in a characteristic fashion, and not all thyroid hor-
mone effects are observed in all responsive tissues. Brain
mitochondria have been generally considered to be nonre-
sponsive to thyroidal state, as no changes in O2 consumption
in either adult or neonatal rats have been found (23). Nev-
ertheless, some biochemical analyses have suggested that
neonatal hypothyroidism causes an alteration of brain mi-
tochondria (24, 25). Along this line, we have recently re-
ported a significant decrease in mitochondrial gene expres-
sion during brain development as well as an induction after
thyroid hormone treatment (10).
In view of these data, the present study was designed to
determine whether alterations in brain mitochondrial gene
expression in hypothyroid neonatal animals could result in
alterations in mitochondrial structure and function and,
therefore contribute to the well known dramatic conse-
quences of thyroid hormone deficit during brain develop-
ment. To this end, we performed a flow cytometric analysis
together with electron microscopic studies of ultrathin sec-
tions of the cerebral cortex, striatum, and hippocampus of
15-day-old control and hypothyroid rats. Our results show a
drop in mitochondrial transmembrane potential (DCm) in
hypothyroid brain, which is corrected after a long treatment
with thyroid hormone. This is associated with alterations in
the number of cristae membranes and large intracristal
spaces in the neurons of all of the areas studied besides the
pyramidal neurons of the CA1 field of the hippocampus and
the nonneural population. In addition, to better define the
role that T3 plays in regulating mitochondrial transcription,
we have analyzed the DNA-binding capacities of brain mi-
tochondrial extracts from control, hypothyroid, and T3-in-
jected 15-day-old animals throughout an approximately
900-bp region containing well characterized control elements
within the displacement loop region of the mitochondrial
DNA (mtDNA). We have observed a T3-dependent DNA-
binding activity with a mtDNA sequence corresponding to
a conserved region called conserved sequence block II
(CSB-II).
Materials and Methods
Materials
Methyl mercaptoimidazole, T3, rhodamine-123 (Rh-123), glutamate,
malate, succinate, and ADP were obtained from Sigma Chemical Co. (St.
Louis, MO). Radiolabeled [a-32P]deoxy-CTP, [g-32P]ATP, and DNA la-
beling systems were purchased from Amersham Corp. (Aylesbury, UK)
and Pharmacia LKB Biotechnology (Piscataway, NJ), respectively. All
other chemicals were reagent or molecular biology grade.
Animal treatment
All animal experiments were conducted in accordance with the Span-
ish Guidelines for the Care and Use of Laboratory animals. Female
Wistar rats were mated, and the day of appearance of the vaginal plug
was considered day 0 of fetal age. To induce fetal and neonatal hypo-
thyroidism, dams were given 0.02% methyl mercaptoimidazole in the
drinking water on day 9 of gestation. To assure very low levels of T3 in
the brain, 5 days after birth the pups were injected with 131I (150 mCi/100
g BW) to destroy all thyroidal tissue. Methyl mercaptoimidazole treat-
ment was continued throughout the period of lactation. With this treat-
ment, T3 values were below the level of detectability. For T3 treatment,
hypothyroid animals were daily injected with 200 mg T3/100 g BW and
killed 48 h (flow cytometry analysis) or 72 h. (electron microscopy
studies) later. After being weighed, the animals from all groups were
killed by decapitation on postnatal day 15, and the brain was quickly
removed and used for mitochondria isolation or electron microscopy
studies.
Isolation of mitochondria
Purified brain mitochondria were prepared as described previously
(26). The tissue was minced, washed, and homogenized manually in 0.32
m sucrose, 1 mm EDTA, 10 mm Tris-HCl (pH 7.4), and 0.1% BSA. The
homogenate was centrifuged at 2,000 3 g for 3 min. The precipitate was
discarded, and the supernatant was centrifuged again at 12,500 3 g for
another 10 min to yield the crude mitochondrial pellet. This mitochon-
drial pellet was resuspended in 0.03 m sucrose, 0.12 m manitol, 0.025 mm
EDTA, 10 mm Tris-HCl (pH 7.4), and 3% (wt/vol) Ficoll. This suspension
(3 ml) was layered onto 7 ml of a discontinuous gradient of Ficoll
(7.5–13%) and centrifuged at 99,000 3 g for 30 min. The pellet was
washed twice, centrifuged at 12,500 3 g, and resuspended in homog-
enization medium.
Preparation of mitochondrial extracts
Mitochondrial extracts were prepared from brains of 15-day-old con-
trol, hypothyroid, and T3-injected animals. Mitochondrial pellets, iso-
lated as described above, were resuspended in lysis buffer [20 mm Tris
HCl (pH 8.0), 0.2 mm EDTA, 10% glycerol, 0.35 m NaCl, 1% Triton X-100,
and 1 mm dithiothreitol] containing 1 mm phenylmethylsulfonylfluo-
ride. The mitochondrial suspension was vigorously vortexed and al-
lowed to stand on ice for 15 min. The mitochondrial lysate was then spun
at 45,000 rpm for 1 h. Protein was determined in the supernatant, and
fractions were frozen and stored at 270 C.
Mobility shift assays
Three DNA probes were obtained by amplifying three different se-
quences of the rat mitochondrial promoter spanning nucleotides 15,401–
15,750, 15,751–16,012, and 16,065–16,298 and labeled using Klenow DNA
polymerase and [32P]deoxy-CTP. Two double stranded oligonucleotides
corresponding to two conserved sequence blocks in the mitochondrial
promoter (CSB-II and CSB-III) and one oligonucleotide from nucleotides
16,167–16,192 were also obtained and labeled using [g-32P]ATP and T4
polynucleotide kinase. The gel shift mixture (20 ml) contained 10 mm
Tris-HCl (pH 8.5), 10 mm MgCl2, 10 mm KCl, 1 mm dithiothreitol, 100
mg BSA, 2 mg poly(dI-dC), 10 mg mitochondrial protein, and 105 dpm of
the indicated 32P-labeled DNA probes or oligonucleotides. This mixture
was incubated at room temperature for 30 min before electrophoresis on
4% nondenaturing polyacrylamide gels in 89 mm Tris, 89 mm borate, and
2 mm EDTA. Gels were run at 200 V for 2–3 h, dried, and exposed for
autoradiography. The experiments were performed three times using
different animals.
Flow cytometry analysis
Isolated mitochondria were analyzed on a FACScan flow cytometer
(Becton Dickinson, San Jose, CA), using CELLQUEST as the data ac-
quiring and analysis software. Except in kinetic experiments, in which
time was used as the limit of acquisition, 10,000 events were acquired
by sample. The mitochondrial fractions were first treated with pro-
pidium iodide (5 mg/ml) to check the membrane integrity. All results
presented here represent the propidium iodide-negative mitochondrial
population. Rh-123 (5 nm) was added at the moment of running the
mitochondria in the flow cytometer, and events were counted for 3 min.
To study the effects of substrates on mitochondrial membrane potential,
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mitochondria were incubated with Rh-123 for 10 min at room temper-
ature. After this, we began time acquisition for 5 min, adding the sub-
strates glutamate (2.5 mm) plus malate (2.5 mm), succinate (5 mm), and
ADP (180 mm) every 90 sec. The mean fluorescence for each substrate
was obtained by gating by time. Values obtained for each experimental
group in the absence of substrates are called basal values. All experi-
ments were carried out three times using different sets of animals.
Electron microscopy
Ultrastructural morphology of mitochondria was determined by
transmission electron microscopy. The brains were cut in the coronal
plane at 1-mm thickness, and sections of cerebral cortex, striatum, and
hippocampus were rapidly fixed with 4% paraformaldehyde-4% glu-
taraldehyde in 0.1 m phosphate buffer. After fixation, the sections
were osmicated in 1% osmium tetroxide for 2 h at 4 C and then
dehydrated in an alcohol-acetone series. Tissues were embedded in
araldite resin, and semithin (2.5 mm) sections were removed for
optical microscopy. Ultrathin sections (50 nm) were mounted on
copper mesh grids and stained with uranyl acetate and lead citrate
before examination with a JEOL JEM 1010 electron microscope (JEOL,
Peabody, MA). All tissue samples were first inspected on 2.5-mm
sections by light microscopy so that the correct area could be deter-
mined. The most internal area of the cerebral cortex and the dentate
gyrus and CA1 field of the hippocampus were selected. The studies
were performed on three different groups of 15-day-old neonates
[euthyroid, hypothyroid, and T3 injected (200 mg/100 g BW)], each
composed of three different animals. Three grids were used for each
animal. Four different morphological groups of mitochondria were
defined (see Fig. 3). They were further divided into two groups
according to the degree of alteration observed: normal (N) and altered
(A). After examining them we assigned each mitochondrium to the
closest morphological group. This was performed without knowing
the source of the tissue examined. Values presented in the histograms
of Figs. 4, 5, and 6 were obtained after examining the morphology of
about 200 mitochondria for each area of the brain (cerebral cortex,
striatum, and hippocampus) and for each animal.
Results
Analysis by flow cytometry of mitochondrial modifications
We used the lipophilic dye Rh-123 to analyze mitochon-
drial function in the brains of 15-day-old neonatal rats during
congenital hypothyroidism. Rh-123 is a cationic fluoro-
chrome that has been reported to accumulate specifically in
the mitochondria through a mechanism that depends on the
mitochondrial membrane potential (27, 28). As shown in Fig.
1A, lower uptake of Rh-123 was observed in brain mito-
chondria from hypothyroid neonates. When average Rh-123-
related fluorescence was calculated, a significant decrease
was detected in the hypothyroid group, 61% of the values
obtained in age-matched euthyroid animals (Fig. 1B). To
evaluate whether the loss in the fluorescence associated with
the uptake of Rh-123 would be reversible, hypothyroid ne-
onates were injected 48 h before death with a dose of T3 that
saturates the nuclear receptor. As shown in Fig. 1, the drop
in mitochondrial membrane potential was totally reversed
by T3 administration to hypothyroid animals, and mitochon-
dria in this experimental group displayed a pattern of Rh-123
labeling similar to that observed for control animals.
As expected, the addition of mitochondrial substrates, suc-
cinate (5 mm) and glutamate plus malate (2.5 mm each),
increased the uptake of Rh-123, and rotenone, an inhibitor of
the respiratory chain, markedly diminished this uptake (Fig.
2A). When control and hypothyroid neonates were com-
pared, we again found a significant decrease in Rh-123 flu-
orescence in the hypothyroid animals compared with that in
the control group. The values presented in Fig. 2B show
117% of the basal signal in control animals, in contrast to
78% in hypothyroid neonates (;17% of increment over
basal values in both cases). When hypothyroid animals
were injected with a saturating dose of T3 and killed 48 h
later, not only was basal Rh-123 uptake normalized, but an
increased response to the addition of substrates was ob-
served (42% over the basal values obtained for the hyper-
thyroid group), suggesting a potentiation of mitochondrial
activity in the hyperthyroid animals, as a saturating dose
of T3 was used. In contrast with the observed effect after
48 h of T3 administration, no effect was noted at shorter (2
h) times, and only a partial recovery was observed 18 h
later (data not shown). Taken together, these results sug-
gest a deficiency of mitochondrial respiratory capacity in
hypothyroid neonates that is corrected after thyroid hor-
mone administration.
FIG. 1. Effect of thyroid hormone on basal Rh-123 uptake by isolated
brain mitochondria. The fluorescence intensity of Rh-123-stained
brain mitochondria from 15-day-old neonates was measured by flow
cytometry. C, Control; Tx, hypothyroid; T3, Tx injected with T3. A, A
representative experiment is shown. B, Quantitation of Rh-123 flu-
orescence. Values are the mean 6 SD percentage from three different
experiments. The value of mitochondrial fluorescence in control an-
imals was considered 100% in each experiment.
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Electron microscopic analysis
To assess whether the decrease in mitochondrial mem-
brane potential observed in hypothyroid animals could be
related to an altered morphology of these organelles, we next
performed a study of mitochondrial structure by electron
microscopy in diverse areas of the brains of 15-day-old con-
trol, hypothyroid, and T3-injected neonates. We observed
that neuronal mitochondria of the cerebral cortex, striatum,
and hippocampus were quite variable in size and shape;
some of the mitochondria were enlarged, whereas others
were globular organelles and distributed apparently at ran-
dom throughout the cytoplasm. However, despite this vari-
ability in the morphology of mitochondria, these can be
classified into two clearly distinguishable types (Fig. 3). Some
of them, which we call normal, have the same basic archi-
tecture of typical neuronal mitochondria, with a highly
folded internal membrane circumscribing a mitochondrial
compartment filled with a dense matrix. On the other hand,
we also observed some mitochondria with a morphology
that we call altered, with a marked decrease in the area of the
inner membrane, a reduction in the number of cristae, a
destructurization of the matrix compartment, and clear
vacuolization.
These two classes of mitochondria were visible in the
three brain areas studied (Figs. 4-6A). Quantitation data of
the different types of mitochondria are shown in Figs.
4 – 6B. The majority of neuronal mitochondria from the
cerebral cortex of control animals presented a normal mor-
phology, with a highly packed inner membrane and a
regular disposition of the cristae; only a minor fraction
(12%) belonged to the altered type. However, a great pro-
portion of hypothyroid mitochondria harbor dramatic al-
terations in the mitochondrial structures, and in hypothy-
roid neonates, a significant increase in the number of
altered mitochondria was observed compared with those
found in age-matched euthyroid animals (57% and 12%,
respectively; Fig. 4B). The changes observed consist
mainly of a marked reduction on the surface of the inner
membrane and vacuolization of the matrix compartment.
Different stages of membrane disintegration, from minor
disarrangements of the inner membrane to empty vesic-
ular structures, can be seen. Similar results were obtained
with the neurons of the striatum (Fig. 5) and the granular
neurons of the dentate gyrus (Fig. 6). In contrast, we did
not observe any difference in the ratio of normal to altered
mitochondria between control and hypothyroid rats in the
pyramidal neurons of the hippocampal field CA1 (data not
shown). In these neurons, about a 50% of the mitochondria
were normal, and the other 50% belonged to the altered
type in both control and hypothyroid neonates. On the
FIG. 2. Effects of different substrates on Rh-123 uptake by isolated
brain mitochondria. The fluorescence intensity of Rh-123-stained
brain mitochondria from 15-day-old neonates was measured by flow
cytometry. C, Control; Tx, hypothyroid; T3, hypothyroid injected with
T3. A, A representative experiment corresponding to a T3-injected
animal is shown (B, Basal; Sc, succinate; M/G, malate plus glutamate;
A, ADP; R, rotenone). B, Quantitation of Rh-123 fluorescence in the
presence of succinate, malate/glutamate, and ADP (S). Values are the
mean 6 SD percentage from three different experiments. The basal
value of mitochondrial fluorescence of control animals was considered
100% in each experiment.
FIG. 3. Representative electron micrographs illustrating two differ-
ent typical kinds of mitochondria. N, Normal morphology; A, altered
morphology; CC, cerebral cortex; St, striatum; DG, dentate gyrus. Bar
scale 5 100 nm. Magnification, 380,000.
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other hand, nonneuronal cells, such as astrocytes and oli-
godendrocites, did not present a high proportion of altered
mitochondria in the hypothyroid animals, and the ratio of
normal to altered was the same in both control and hy-
pothyroid groups, with a great percentage (80 –90%) of
mitochondria with no morphological alterations (data not
shown). The fact that hypothyroidism did not affect the
CA1 neurons and the nonneuronal cells suggests that the
effect of thyroid hormone is specific and differential. Also,
the aberrant mitochondrial structures were not prepara-
tion or fixation artifacts, as the integrity of other subcel-
lular organelles (not shown in the pictures) affirms good
subcellular preservation. Thyroid hormone administra-
tion to hypothyroid neonates resulted in a normalization
of mitochondrial morphology. Quantitation of the number
of altered mitochondria, compared with normal (Figs.
4 – 6B), resulted in a similar percentage of both populations
between control and hyperthyroid animals. No effect of T3
injection was observed in the neurons of the CA1 hip-
pocampal field or in nonneuronal cells (data not shown).
These morphological alterations are in accordance with
the flow cytometry data, showing a decrease in membrane
potential, which is a reflection of a reduction in the respira-
tory activity of the mitochondria.
Gel retardation analysis of the mtDNA promoter region
Mammalian mitochondrial DNA is bidirectionally tran-
scribed from a heavy strand and a light strand promoter.
These promoters are both localized to the mayor regulatory
region for mtDNA transcription and replication in the only
extensive noncoding area, called the displacement loop (D-
loop) (29). To gain further insight into how thyroid hormone
could regulate mitochondrial gene expression, we next per-
formed electrophoretic mobility shift assays to determine
whether thyroid status could influence the binding of some
mitochondrial protein to this regulatory region of the
mtDNA. As indicated in Materials and Methods, three differ-
ent DNA fragments, covering the region of the D-loop from
nucleotides 15,401–16,298, were obtained. Brain mitochon-
drial extracts were prepared from euthyroid, hypothyroid,
and hypothyroid T3-injected animals and tested for DNA-
FIG. 4. Effect of thyroid hormone on neuronal mitochondrial mor-
phology from cerebral cortex. C, Control; Tx, hypothyroid; T3, hypo-
thyroid injected with T3. A, Representative electron micrographs. Bar
scale 5 80 nm. Magnification, 330,000. B, Quantitation (percentage)
of normal and altered mitochondria. Values are the mean 6 SD from
three different 15-day-old neonates.
FIG. 5. Effect of thyroid hormone on neuronal mitochondrial mor-
phology from striatum. C, Control; Tx, hypothyroid: T3, hypothyroid
injected with T3. A, Representative electron micrographs. Bar scale 5
80 nm. Magnification, 330,000. B, Quantitation (percentage) of nor-
mal and altered mitochondria. Values are the mean 6 SD from three
different 15-day-old neonates.
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binding activity. As shown in Fig. 7A, binding activity was
highest in the extracts from control rat brain and was lowest
in the hypothyroid extract when DNA fragment 16,065/
16,298 was used. These differences were consistently ob-
served. The binding activity was recovered 24 h after thyroid
hormone administration to hypothyroid neonates. On the
contrary, no differences were detected when the other
mtDNA regulatory sequences, DNA fragments 15,401/
15,750 and 15,751/16,012, were tested (data not shown). We
next investigated more precisely the DNA sequence respon-
sible for this DNA-binding activity. To this end, we designed
three different oligonucleotides corresponding to two con-
served sequence blocks in the D-loop region (CSB-II and
CSB-III) as well as an oligonucleotide from nucleotides
16,167–16,192, all of them within the region that caused a
retardation dependent on thyroid state. As shown in Fig. 7B,
we observed that the T3-dependent protein-DNA binding is
localized to the CSB-II region. The other two oligonucleotides
tested did not present any T3-dependent DNA-binding ac-
tivity. A 200-fold molar excess of unlabeled oligonucleotide
abolished the formation of the shifted band, indicating spec-
ificity of binding. Unrelated oligonucleotides (CSB-III and
oligonucleotide from nucleotides 16,167–16,192) did not pre-
vent formation of the retarded band (data not shown).
Discussion
The present report clearly shows that brain mitochondria
are targets of thyroid hormone action during development,
as alterations in mitochondrial structure and function are
observed in the brains of hypothyroid animals and are cor-
rected after T3 administration. These results are particularly
important considering that until very recently (10) it was
generally assumed that brain mitochondria were not respon-
sive to thyroidal state, and because morphological alterations
were detected in neuronal cells, but not in the glial popula-
tion, suggesting that neurons are particularly sensitive to the
lack of T3, with the important consequences that this should
have in brain development.
The general organization of the mitochondrial inner mem-
brane cristae into the typical transverse alignment in control
animals was largely absent in the mitochondria isolated from
hypothyroid brain. These mitochondria were characterized
by highly fractured and degenerated cristae and a clear vac-
uolation. The drop in mitochondrial membrane potential,
observed by flow cytometry in total brain mitochondria of
hypothyroid animals, is probably a reflection of the de-
creased surface area of the inner membrane observed in
neuronal cells in the electron microscopic study because in
this membrane all enzymes of the respiratory chain are
present.
As we noted above, until recently it has been generally
considered that brain mitochondria were insensible to the
action of T3. However, there were some reports indicating
that mitochondrial alterations could be occurring in the
brains of hypothyroid animals. An alteration in phospho-
lipid composition and membrane fluidity of rat brain mito-
chondria has been reported (30) as well as some alterations
of oxidative phosphorylation (31). We recently found that
differences in thyroidal state during development result in
profound alterations of mitochondrial gene expression (10).
All of these data together with the results of the present study
clearly indicate that mitochondrial function can be severely
impaired in the hypothyroid brain, and that T3 can counter-
act this event. These findings provide a biochemical basis for
the known alterations of brain function as a consequence of
the lack of thyroid hormone during brain development. This
is particularly important in view of the growing evidence
that primary defects in mitochondrial function are impli-
cated in over 100 diseases, and that the clinical manifestations
most often involve the central nervous system (Kearns-Sayre
syndrome, MERFF, MELAS, etc.). In addition, mitochondrial
dysfunction have now been found to occur in aging and in
age-related degenerative diseases affecting brain function,
such as Parkinson’s and Alzheimer’s diseases (32).
Alterations in mitochondrial morphology caused by hy-
pothyroidism have been described in other tissues, such as
liver and skeletal muscle (33, 34), and the modifications are
essentially the same as those described here for the devel-
oping brain. In the liver, Jakovcic et al. (35) also reported
hypothyroid mitochondria to be shorter and wider than
those in controls, and some swelling after T3 administration
FIG. 6. Effect of thyroid hormone on neuronal mitochondrial mor-
phology from dentate gyrus. C, Control; Tx, hypothyroid: T3, hypo-
thyroid injected with T3. A, Representative electron micrographs. Bar
scale 5 80 nm. Magnification, 330,000. B, Quantitation (percentage)
of normal and altered mitochondria. Values are the mean 6 SD from
three different 15-day-old neonates.
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has also been observed (33). In skeletal muscle, the adminis-
tration of T3 to hypothyroid animals results in an increase in the
number of cristae, accompanied by some hypertrophy (33). The
results of the flow cytometric analysis and electron microscopic
studies shown here also revealed small differences in size be-
tween the brain mitochondria of control and hypothyroid ne-
onates. Although the alterations found in mitochondrial mor-
phology in the hypothyroid animals are essentially the same
between liver and brain, our data, showing a drop in brain
mitochondrial transmembrane potential in these animals, are
different from the situation in the liver. There are several reports
showing a lowering of the mitochondrial membrane potential
after T3 administration to euthyroid rats (36, 37). It has been
proposed that the decrease in DCm in hyperthyroid liver mi-
tochondria is the result of a nonspecific thyroid hormone-in-
duced increase in proton conductance of the mitochondrial
inner membrane (proton leak). Thus, there is a clear difference
in the response of brain and liver mitochondria to thyroid
hormone status, suggesting a tissue-specific effect of thyroid
hormone on brain mitochondria.
An interesting point is the observation of a clear differ-
ential responsiveness to T3 in the mitochondria of the dif-
ferent neurons. Whereas granular neurons mitochondria of
the dentate gyrus respond to T3 in the same fashion as those
of the cerebral cortex or striatum, mitochondria of the py-
ramidal neurons from the CA1 field of the hippocampus are
not sensitive to thyroidal state. These results together with
recent reports showing a differential effect of thyroid hor-
mone on brain gene expression depending on the area stud-
ied and the age of the animal (14, 38) point to a very complex
effect of hypothyroidism on brain development, where dif-
ferent kinds of neurons respond to this hormone in very
different fashions. The variability in the response to thyroid
hormone suggests a modulation of T3 action on gene ex-
pression for other cellular factors differentially expressed in
different brain cell types.
The next step toward a better understanding of the role of
T3 in mitochondrial function must include studies of the
molecular mechanisms underlying T3 action. There are some
reports showing very rapid effects of thyroid hormone on
hepatic mitochondrial activity in vivo (39), which have been
suggested to be mediated by a direct effect of the T3 metab-
olites 3,39-diiodothyronine and 3,59-diiodothyronine on the
mitochondria (40). This is in contrast to the effect of thyroid
hormone that we have observed on brain mitochondrial ac-
tivity, as this one requires a much longer period to be ob-
served, suggesting that it is related to changes in mitochon-
drial gene expression (10). Although the presence of thyroid
hormone receptors has been recently described in rat liver
mitochondria (41, 42), a better explanation of the T3 effects on
these organelles could be the existence of a T3-regulated
mediator between T3 nuclear receptors and the mitochon-
dria, as the effects of thyroid hormone on the expression of
nuclear and mitochondrially encoded genes are coordinate
(10, 43). Good candidates for mediators are the nuclear re-
spiratory factor-I protein (44), which is known to regulate the
mitochondrial transcription factor A (mtTFA) (45), the
mtTFA itself, or another protein necessary for mitochondrial
transcription and not yet characterized.
In an attempt to know the possible existence of one of these
mediators, in this work we have analyzed the protein-DNA
binding activity on the regulatory region of the mtDNA and
its response to thyroidal status. The mammalian mitochon-
drial DNA possesses a region called the D-loop, which is the
main noncoding region and the most variable part of ver-
tebrate mitochondrial genomes. This region contains the or-
igin of heavy strand DNA replication and the promoters for
heavy and light strand transcription (29). Within this region
there are three conserved sequence blocks, called CSB-I, CSB-II,
and CSB-III, that are thought to be involved in mtDNA repli-
cation and transcription. Our findings show that rat brain mi-
tochondrial extracts contain a protein(s) that binds to a specific
FIG. 7. DNA-binding activity of the mitochondrial protein extracts. Binding and electrophoresis conditions are described in Materials and
Methods. A, Binding to DNA fragment 16,065/16,298. The left and right panels correspond to two different animals. B, Binding to oligonucleotides
CSB-II, CSB-III, and 16,167/16,192.
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sequence (CSB-II) in the mitochondrial regulatory region. The
binding activity of the protein(s) was influenced by the thyroid
status of the animal, suggesting that T3 regulates mitochondrial
gene expression through the control of proteins that bind to
regulatory sequences responsible for controlling mitochondrial
transcription. However, additional studies will be necessary to
identify these proteins and establish their function and whether
they could act as a link between the nuclear receptor for T3 and
its action in the mitochondria.
In summary, this work provides evidence that the changes
in mitochondrial gene expression during development in the
hypothyroid neonatal brain, previously reported by our lab-
oratory (10), result in an impaired mitochondrial function
and in the appearance of a population of neuronal mito-
chondria with severely altered structure. This work thus
shows for the first time that the lack of thyroid hormone in
the developing brain can severely alter mitochondrial struc-
ture and function and, in consequence, provides a cellular
basis for the observed dependency on T3 of the developing
brain. Finally, our findings supply initial information about
the mechanism by which thyroid hormone can influence
brain mitochondrial gene expression.
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